首页> 外文期刊>Therapeutic advances in gastroenterology. >Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance
【24h】

Tryptase mast cell density, protease-activated receptor-2 microvascular density, and classical microvascular density evaluation in gastric cancer patients undergoing surgery: possible translational relevance

机译:胰蛋白酶肥料细胞密度,蛋白酶活化受体-2微血管密度,胃癌患者患者进行手术的典型微血管密度评估:可能的翻译相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Mast cells (MCs) can stimulate angiogenesis, releasing several proangiogenic cytokines stored in their cytoplasm. In particular, MCs can release tryptase, a potent in vivo and in vitro proangiogenic factor via protease-activated receptor-2 (PAR-2) activation and mitogen-activated protein kinase (MAPK) phosphorylation. Nevertheless, no data are available concerning the relationship among tryptase MC density (TMCD), endothelial cells (ECs) positive to PAR-2 microvascular density (PAR-2-MVD) and classical MVD (C-MVD) in gastric cancer (GC) angiogenesis.
机译:背景:肥大细胞(MCS)可以刺激血管生成,释放储存在其细胞质中的几种常规细胞因子。 特别地,MCS可以通过蛋白酶活化的受体-2(PAR-2)活化和丝裂剂活化的蛋白激酶(MAPK)磷酸化释放胰蛋白酶酶,体内和体外致致因子的效率。 然而,没有关于胃癌(GC)中的胰蛋白酶MC密度(TMCD),内皮细胞(ECS),内皮细胞(ECS)和癌症(GC)中古典MVD(C-MVD)的关系的关系 血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号